Vijay Pande, a common companion at Andreessen Horowitz who based the agency’s a16z Bio+ Well being technique, introduced that he’s stepping down from his position.
Since its founding in 2014, a16z Bio+ Well being has raised 4 funds of almost $3 billion every, together with a $1.5 billion fund that closed in 2022. Nonetheless, it’s now in search of a a lot smaller $750 million fifth fund, The Wall Road Journal reported. In January, a16z Bio+ Well being introduced that it’s going to handle a $500 million biotech fund funded by pharmaceutical large Eli Lilly.
a16z Bio + Well being backs digital well being startups and corporations on the intersection of AI, computation, and biology.
Pande’s investments embrace Devoted Well being, an individualized medical plan supplier; Operate Well being, a customized lab testing startup; and Freenome, an organization aiming to detect most cancers by way of blood attracts. Earlier than becoming a member of Andreessen Horowitz, Pande was a professor of chemistry, structural biology, and pc science at Stanford College.
The remaining companions on the a16z Bio + Well being crew are Jorge Conde, Julie Yoo, and Vineeta Agarwala.
{content material}
Supply: {feed_title}